177 related articles for article (PubMed ID: 30179262)
1. Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept.
Hess J; Su L; Nizzi F; Beebe K; Magee K; Salzberg D; Stahlecker J; Miller HK; Adams RH; Ngwube A
Transfusion; 2018 Sep; 58(9):2122-2127. PubMed ID: 30179262
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia.
Park JA; Lee HH; Kwon HS; Baik CR; Song SA; Lee JN
Transfus Med Rev; 2016 Jan; 30(1):6-14. PubMed ID: 26481836
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease.
Raj A; Bertolone S; Cheerva A
J Pediatr Hematol Oncol; 2004 May; 26(5):312-4. PubMed ID: 15111785
[TBL] [Abstract][Full Text] [Related]
4. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
[TBL] [Abstract][Full Text] [Related]
5. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
Ahmed I; Teruya J; Murray-Krezan C; Krance R
Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
[TBL] [Abstract][Full Text] [Related]
6. Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report.
Hoffmann J; Schliesser G; Neubauer A
Hematology; 2023 Dec; 28(1):2208010. PubMed ID: 37133319
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital.
Wang M; Wang W; Abeywardane A; Adikarama M; McLornan D; Raj K; de Lavallade H; Devereux S; Mufti GJ; Pagliuca A; Potter VT; Mijovic A
Biol Blood Marrow Transplant; 2015 Jan; 21(1):60-6. PubMed ID: 25262883
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of autoimmune hemolytic anemia after pediatric allogeneic stem cell transplant.
Hillier K; Harris EM; Berbert L; Pai SY; Grace RF
Pediatr Blood Cancer; 2022 Jan; 69(1):e29410. PubMed ID: 34709706
[TBL] [Abstract][Full Text] [Related]
9. Fatal immune hemolytic anemia following allogeneic stem cell transplantation: report of 2 cases and review of literature.
Rovira J; Cid J; Gutiérrez-García G; Pereira A; Fernández-Avilés F; Rosiñol L; Martínez C; Carreras E; Urbano A; Rovira M; Lozano M
Transfus Med Rev; 2013 Jul; 27(3):166-70. PubMed ID: 23562007
[TBL] [Abstract][Full Text] [Related]
10. Risk factor analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children.
Chang TY; Jaing TH; Wen YC; Huang IA; Chen SH; Tsay PK
Medicine (Baltimore); 2016 Nov; 95(46):e5396. PubMed ID: 27861376
[TBL] [Abstract][Full Text] [Related]
11. Immune hemolytic anemia--selected topics.
Hoffman PC
Hematology Am Soc Hematol Educ Program; 2009; ():80-6. PubMed ID: 20008185
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.
O'Connell N; Goodyer M; Gleeson M; Storey L; Williams M; Cotter M; O'Marcaigh A; Smith O
Pediatr Transplant; 2014 Feb; 18(1):E22-4. PubMed ID: 24168326
[TBL] [Abstract][Full Text] [Related]
13. Abatacept treatment for autoimmune hemolytic anemia occurring post hematopoietic stem cell transplantation.
Gabelli M; Pérez-Martínez A; Bueno Sánchez D; Lucchini G; Grenier LP; Couture F; Limerick E; Bernaud V; Trabazo Del Castillo M; Ngwube A
Bone Marrow Transplant; 2024 Feb; 59(2):288-290. PubMed ID: 38097758
[No Abstract] [Full Text] [Related]
14. Allogeneic stem cell transplantation for Evans syndrome.
Oyama Y; Papadopoulos EB; Miranda M; Traynor AE; Burt RK
Bone Marrow Transplant; 2001 Nov; 28(9):903-5. PubMed ID: 11781654
[TBL] [Abstract][Full Text] [Related]
15. [A case of autoimmune hemolytic anemia complicating hematopoietic cell transplantation].
Chae H; Kim Y; Kim M; Lim J; Han K; Cho SG; Lee JW
Korean J Lab Med; 2008 Feb; 28(1):64-9. PubMed ID: 18309257
[TBL] [Abstract][Full Text] [Related]
16. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Karlsson C; Hansson L; Celsing F; Lundin J
Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
[TBL] [Abstract][Full Text] [Related]
17. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
Radhi M; Rumelhart S; Tatman D; Goldman F
J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation.
Horn B; Viele M; Mentzer W; Mogck N; DeSantes K; Cowan M
Bone Marrow Transplant; 1999 Nov; 24(9):1009-13. PubMed ID: 10556961
[TBL] [Abstract][Full Text] [Related]
19. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
[TBL] [Abstract][Full Text] [Related]
20. Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.
Cheung WW; Hwang GY; Tse E; Kwong YL
Haematologica; 2006 May; 91(5 Suppl):ECR13. PubMed ID: 16709521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
